Schroder Investment Management Group Decreases Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Schroder Investment Management Group decreased its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 25.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,326 shares of the company’s stock after selling 14,850 shares during the period. Schroder Investment […]

Related Keywords

Montreal ,Quebec ,Canada ,Floydf Petersen ,Williamj Peters , ,Quarter For Amphastar Pharmaceuticals ,Nasdaq ,Amphastar Pharmaceuticals Profile ,Raymond James Associates ,York Mellon Corp ,Schroder Investment Management Group ,Citigroup Inc ,News Ratings For Amphastar Pharmaceuticals Daily ,Envestnet Asset Management Inc ,Amphastar Pharmaceuticals ,Amphastar Pharmaceuticals Trading ,Securities Exchange Commission ,Amphastar Pharmaceuticals Inc ,Get Rating ,Investment Management Group ,Asset Management ,New York Mellon Corp ,Montreal Can ,Director Floyd ,Finished Pharmaceutical Products ,Active Pharmaceutical Ingredients Products ,Visit Holdingschannel ,Amphastar Pharmaceuticals Daily ,